Cargando…
Effect of spironolactone on vascular stiffness in hemodialysis patients: a randomized crossover trial
BACKGROUND: The role of spironolactone treatment in hemodialysis patients is debated, but a survival benefit is suggested. Mineralocorticoids and chronic kidney disease have been linked to cardiovascular fibrosis. Therefore, we hypothesized that spironolactone would affect vascular stiffness, cardia...
Autores principales: | Eklund, Michael, Hellberg, Olof, Furuland, Hans, Cao, Yang, Wall, Kent, Nilsson, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169545/ https://www.ncbi.nlm.nih.gov/pubmed/35722182 http://dx.doi.org/10.48101/ujms.v127.8594 |
Ejemplares similares
-
Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial
por: Eklund, Michael, et al.
Publicado: (2021) -
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study
por: Bousquet, Elodie, et al.
Publicado: (2015) -
Effects of Spironolactone on Arrhythmias in Hemodialysis Patients: Secondary Results of the SPin-D Randomized Controlled Trial
por: Mc Causland, Finnian R., et al.
Publicado: (2023) -
Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023) -
Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019)